Literature DB >> 13370493

Anaphylaxis in the mouse: possible relation of the Schultz-Dale reaction to serotonin release.

M A FINK.   

Abstract

Entities:  

Keywords:  ALLERGY/experimental; SEROTONIN/metabolism

Mesh:

Substances:

Year:  1956        PMID: 13370493     DOI: 10.3181/00379727-92-22579

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


× No keyword cloud information.
  12 in total

Review 1.  [ENZYMATIC PROCESSES IN THE PATHOGENESIS OF ALLERGIC REACTIONS].

Authors:  W RAAB; E KAISER
Journal:  Klin Wochenschr       Date:  1965-04-01

2.  [On the substance liberated in anaphylactic and allergic reaction].

Authors:  G ENGELHARDT; U SCHWABE
Journal:  Klin Wochenschr       Date:  1960-02-15

3.  [The current status of research on mast cells].

Authors:  G NIEBAUER
Journal:  Klin Wochenschr       Date:  1960-07-15

4.  [The theoretical principles of allergy].

Authors:  F HAHN; H GIERTZ
Journal:  Arch Ohren Nasen Kehlkopfheilkd       Date:  1960

5.  Serotonin and histamine release during anaphylaxis in the rabbit.

Authors:  T P WAALKES; H WEISSBACH; J BOZICEVICH; S UDENFRIEND
Journal:  J Clin Invest       Date:  1957-07       Impact factor: 14.808

Review 6.  The Schultz-Dale reaction: a review.

Authors:  N Chand; P Eyre
Journal:  Agents Actions       Date:  1978-04

Review 7.  Histamine-sensitizing factors from microbial agents, with special reference to Bordetella pertussis.

Authors:  J Munoz; R K Bergman
Journal:  Bacteriol Rev       Date:  1968-06

8.  Oxatomide protects Trichinella spiralis infected mice from lethal anaphylaxis.

Authors:  F De Clerck; L Van Gorp; O Vanparijs; M Borgers; F Awouters
Journal:  Agents Actions       Date:  1978-12

9.  On the nature of the chemical mediators involved in anaphylactic reactions in mice.

Authors:  B N HALPERN; T NEVEU; S SPECTOR
Journal:  Br J Pharmacol Chemother       Date:  1963-06

10.  Requirement for vasoactive amines for production of delayed-type hypersensitvity skin reactions.

Authors:  R K Gershon; P W Askenase; M D Gershon
Journal:  J Exp Med       Date:  1975-09-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.